Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5539684 | 0.80 | GABRR1 (0.44) | GABRR1CYP1A2 | |
| SCHEMBL16749901 | 0.80 | GABRR1 (0.44) | GABRR1CYP1A2 | |
| SCHEMBL250969 | 0.80 | GABRR1 (0.44) | GABRR1CYP1A2 | |
| SCHEMBL22396499 | 0.78 | GABRR1 (0.42) | GABRR1CYP1A2 | |
| SCHEMBL7698226 | 0.72 | ACACB (0.42) | GABRR1CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL8858431 | 0.70 | ACACB (0.41) | GABRR1CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL8858432 | 0.70 | ACACB (0.41) | GABRR1CYP1A2 | |
| SCHEMBL5568672 | 0.69 | GABRR1 (0.35) | GABRR1CYP1A2 | |
| SCHEMBL25069182 | 0.69 | GABRR1 (0.32) | GABRR1CYP1A2 | |
| Tetramethylammonium Ion SCHEMBL8858456 | 0.67 | ACACB (0.38) | GABRR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10343978-B2 | Process for producing long chain amino acids and dibasic acids | VITAWORKS IP, LLC (US) | 2019-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343978-B2 | Process for producing long chain amino acids and dibasic acids | FASN, DAO, ALKBH3 | GABRR1 409/4885CYP1A2 729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.